Triglyceride Omega-3 Fish Oil (2g EPA+DHA per serving)
A triglyceride-form fish oil delivering 2 g combined EPA and DHA per serving. Dosage matters: cardiovascular benefits in trials cluster at higher daily EPA/DHA intakes.
Resar evidence panel
0–100 · cited research only
Evidence Score
90
Excellent
Safety Score
59
Good
Effectiveness Score
81
Strong
Research Confidence
82
Strong
Product Fit Score
68
Good
Bottom line
Strong evidence (Excellent) for heart health — worth a closer look if this fits your goals.
Individual results vary. Summaries are educational — not medical advice.
Evidence Score
90
Excellent
Price
$45.95
Resar may earn an affiliate commission on this purchase. Commissions never change scores — see our affiliate disclosure and conflicts policy. Scores reflect cited research, not medical advice.
Compare others in Heart HealthTop research
The strongest studies behind this product
Ranked by evidence hierarchy and how closely each study matches this product. Start with the strongest study, then read down. Every claim needs a trail.
Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials
Meta Analysis · Journal of the American Heart Association · 2019 · n=127,477
What the research shows
Significant reductions in several cardiac endpoints; effect strengthened with higher daily EPA+DHA.
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
Systematic Review · Circulation · 2019
Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression
Meta Analysis · Mayo Clinic Proceedings · 2021 · n=149,051
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Systematic Review · Cochrane Database of Systematic Reviews · 2020
Scores reflect these cited studies, not medical advice. Expand the full evidence detail below for protocols, dose context, and reported side effects.
Did this clinical breakdown make sense?
Share this evidence report
Send a link to this page so others can read the same breakdown.
Claim ledger
Every claim, mapped to its source
Each product claim below is tied to a specific paper with study type, match strength, and limitations. Nothing here is medical advice — it is a research trail you can audit.
Claim match reflects how closely a specific paper supports this benefit — not AI confidence or medical certainty.
Full evidence detail
Study-by-study breakdown
Each paper below is ranked for this listing. Start with the highest match, then expand any study for a plain-language readout.
How to read this section
- Match % - how closely the study matches this product (not overall scientific quality).
- Evidence type - study design (RCT, review, etc.) and whether it is direct, category-level, or indirect.
- What it found - short summary and quoted extract from the paper metadata. Not medical advice.
In plain language
What the study reported
Verified extract — not AI generated
“Significant reductions in several cardiac endpoints; effect strengthened with higher daily EPA+DHA.”
Benefit associated with doses above ~1 g/day, strengthening toward 2-4 g/day.
Omega-3 supplements were generally safe; mild GI upset and a small increase in atrial fibrillation risk noted in some high-dose trials.
Caveats
Trials varied in dose, formulation and populations; not all endpoints (e.g., stroke) showed benefit.
Transparency
Score history
Human review is pending for this listing.
Reviews
Shopper feedback
4.7
average rating
8,890 Amazon reviews were available from the listing metadata.